SAM #36C26026Q0851

VA Solicitation for NGS-Based MRD Testing Services in Hematologic Malignancies

The Department of Veterans Affairs, Veterans Healthcare Administration, Network Contracting Office 20, is seeking a contractor to provide specialized Reference Laboratory Services for Measurable Residual Disease (MRD) testing in hematologic malignancies for the VA Portland Healthcare System. - Government Buyer: - Department of Veterans Affairs - Veterans Healthcare Administration - Network Contracting Office 20 (Portland) - Services Requested: - Reference laboratory MRD testing for multiple myeloma, B-cell acute lymphoblastic leukemia, and chronic lymphocytic leukemia - Testing must use FDA-cleared, next generation sequencing (NGS)-based assays - Services include specimen testing, result interpretation, testing supplies, customer service, secure electronic results delivery, technical support, and compliance with CLIA and CAP accreditation - Turnaround time requirement: 6 business days - Quantities: - 10 tests per year, for a total of up to 50 tests over five years (base year plus four option years) - Unique/Notable Requirements: - Testing must be performed using FDA-cleared NGS-based MRD assays - Contractor must provide all necessary supplies and ensure secure, electronic delivery of results - Laboratory must be CLIA and CAP accredited - Strict turnaround time of 6 business days for results - No specific OEMs or vendors are named in the solicitation - All technical and service details are specified in the solicitation attachment

Description

Reference Laboratory Services for Measurable Residual Disease (MRD) detection in hematologic malignancies.More details of requirement in Attachment titled Solicitation 36C26026Q0851.

View original listing